128 related articles for article (PubMed ID: 31297950)
1. Laser-induced plasmon-mediated treatment of retinoblastoma in viscous vitreous phantom.
Darviot C; Hardy P; Meunier M
J Biophotonics; 2019 Nov; 12(11):e201900193. PubMed ID: 31297950
[TBL] [Abstract][Full Text] [Related]
2. [The efficacy of large spot indirect ophthalmoscopy laser alone or combined with systemic chemotherapy in retinoblastoma therapy].
Liang JH; Cheng Y; Deng X; Yu YY; Li XX
Zhonghua Yan Ke Za Zhi; 2016 Oct; 52(10):745-748. PubMed ID: 27760646
[TBL] [Abstract][Full Text] [Related]
3. Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor?
Gombos DS; Cauchi PA; Hungerford JL; Addison P; Coen PG; Kingston JE
Br J Ophthalmol; 2006 Sep; 90(9):1168-72. PubMed ID: 16707528
[TBL] [Abstract][Full Text] [Related]
4. Intravitreal chemotherapy and laser for newly visible subretinal seeds in retinoblastoma.
Abramson DH; Catalanotti F; Brodie SE; Kellick MG; Francis JH
Ophthalmic Genet; 2018 Jun; 39(3):353-356. PubMed ID: 29513055
[TBL] [Abstract][Full Text] [Related]
5. Vitreous Seeds in Retinoblastoma: Clinicopathologic Classification and Correlation.
Amram AL; Rico G; Kim JW; Chintagumpala M; Herzog CE; Gombos DS; Chévez-Barrios P
Ophthalmology; 2017 Oct; 124(10):1540-1547. PubMed ID: 28528011
[TBL] [Abstract][Full Text] [Related]
6. Response of retinoblastoma with vitreous tumor seeding to adenovirus-mediated delivery of thymidine kinase followed by ganciclovir.
Chévez-Barrios P; Chintagumpala M; Mieler W; Paysse E; Boniuk M; Kozinetz C; Hurwitz MY; Hurwitz RL
J Clin Oncol; 2005 Nov; 23(31):7927-35. PubMed ID: 16258092
[TBL] [Abstract][Full Text] [Related]
7. Repair of late retinal detachment after successful treatment of retinoblastoma.
Madreperla SA; Hungerford JL; Cooling RJ; Sullivan P; Gregor Z
Retina; 2000; 20(1):28-32. PubMed ID: 10696743
[TBL] [Abstract][Full Text] [Related]
8. Treatment of retinoblastoma vitreous base seeding.
Madreperla SA; Hungerford JL; Doughty D; Plowman PN; Kingston JE; Singh AD
Ophthalmology; 1998 Jan; 105(1):120-4. PubMed ID: 9442787
[TBL] [Abstract][Full Text] [Related]
9. SYK-targeted dendritic cell-mediated cytotoxic T lymphocytes enhance the effect of immunotherapy on retinoblastoma.
Chen X; Kunda PE; Lin J; Zhou M; Huang J; Zhang H; Liu T
J Cancer Res Clin Oncol; 2018 Apr; 144(4):675-684. PubMed ID: 29372378
[TBL] [Abstract][Full Text] [Related]
10. Combination of oncolytic adenovirus and endostatin inhibits human retinoblastoma in an in vivo mouse model.
Wang H; Wei F; Li H; Ji X; Li S; Chen X
Int J Mol Med; 2013 Feb; 31(2):377-85. PubMed ID: 23229955
[TBL] [Abstract][Full Text] [Related]
11. An experimental application of gene therapy for human retinoblastoma.
Hayashi N; Ido E; Ohtsuki Y; Ueno H
Invest Ophthalmol Vis Sci; 1999 Feb; 40(2):265-72. PubMed ID: 9950583
[TBL] [Abstract][Full Text] [Related]
12. Selective nano-thermal therapy of human retinoblastoma in retinal laser surgery.
Khademi R; Razminia A
Nanomedicine; 2020 Feb; 24():102102. PubMed ID: 31678179
[TBL] [Abstract][Full Text] [Related]
13. [Diode laser thermotherapy and chemothermotherapy in the treatment of retinoblastoma].
Lumbroso L; Doz F; Levy C; Dendale R; Vedrenne J; Bours D; Zucker JM; Asselain B; Desjardins L
J Fr Ophtalmol; 2003 Feb; 26(2):154-9. PubMed ID: 12660589
[TBL] [Abstract][Full Text] [Related]
14. Vitreoretinal complications of retinoblastoma treatment.
Tawansy KA; Samuel MA; Shammas M; Murphree AL
Retina; 2006 Sep; 26(7 Suppl):S47-52. PubMed ID: 16946679
[TBL] [Abstract][Full Text] [Related]
15. Focal therapy in the management of retinoblastoma: when to start and when to stop.
Hamel P; Heon E; Gallie BL; Budning AS
J AAPOS; 2000 Dec; 4(6):334-7. PubMed ID: 11124666
[TBL] [Abstract][Full Text] [Related]
16. [Experimental research on in vivo gene-therapy of retinoblastoma].
Chen D; Zhang X; Luo C
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1999 Aug; 16(4):211-5. PubMed ID: 10431044
[TBL] [Abstract][Full Text] [Related]
17. Photoablation of Human Vitreous Opacities by Light-Induced Vapor Nanobubbles.
Sauvage F; Fraire JC; Remaut K; Sebag J; Peynshaert K; Harrington M; Van de Velde FJ; Xiong R; Tassignon MJ; Brans T; Braeckmans K; De Smedt SC
ACS Nano; 2019 Jul; 13(7):8401-8416. PubMed ID: 31287662
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics, Tissue Localization, Toxicity, and Treatment Efficacy in the First Small Animal (Rabbit) Model of Intra-Arterial Chemotherapy for Retinoblastoma.
Daniels AB; Froehler MT; Pierce JM; Nunnally AH; Calcutt MW; Bridges TM; LaNeve DC; Williams PE; Boyd KL; Reyzer ML; Lindsley CW; Friedman DL; Richmond A
Invest Ophthalmol Vis Sci; 2018 Jan; 59(1):446-454. PubMed ID: 29368001
[TBL] [Abstract][Full Text] [Related]
19. Late recurrence of tumor necessitating enucleation in an adult onset retinoblastoma.
Khetan V; Mathur G; Kumar SK; Gopal L
Ophthalmic Genet; 2013; 34(1-2):87-9. PubMed ID: 22950453
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of sodium iodide symporter (NIS) protein expression by an innate immunity component: Promising potential for targeting radiosensitive retinoblastoma.
Samuel J; Singh N; Kanwar JR; Krishnakumar S; Kanwar RK
Exp Eye Res; 2015 Oct; 139():108-14. PubMed ID: 26213306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
